184 related articles for article (PubMed ID: 32308553)
1. Perspectives in HPV Secondary Screening and Personalized Therapy Basing on Our Understanding of HPV-Related Carcinogenesis Pathways.
Celewicz A; Celewicz M; Michalczyk M; Rzepka R
Mediators Inflamm; 2020; 2020():2607594. PubMed ID: 32308553
[TBL] [Abstract][Full Text] [Related]
2. Carcinogenesis Associated with Human Papillomavirus Infection. Mechanisms and Potential for Immunotherapy.
Vonsky M; Shabaeva M; Runov A; Lebedeva N; Chowdhury S; Palefsky JM; Isaguliants M
Biochemistry (Mosc); 2019 Jul; 84(7):782-799. PubMed ID: 31509729
[TBL] [Abstract][Full Text] [Related]
3. HPV: Molecular pathways and targets.
Gupta S; Kumar P; Das BC
Curr Probl Cancer; 2018; 42(2):161-174. PubMed ID: 29706467
[TBL] [Abstract][Full Text] [Related]
4. Vaccines against human papillomavirus.
Lin YY; Alphs H; Hung CF; Roden RB; Wu TC
Front Biosci; 2007 Jan; 12():246-64. PubMed ID: 17127297
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
Berman TA; Schiller JT
Cancer; 2017 Jun; 123(12):2219-2229. PubMed ID: 28346680
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus vaccines for the prevention and treatment of cervical cancer.
Tomson TT; Roden RB; Wu TC
Curr Opin Investig Drugs; 2004 Dec; 5(12):1247-61. PubMed ID: 15648945
[TBL] [Abstract][Full Text] [Related]
7. HPV and HPV-associated diseases.
Dunne EF; Park IU
Infect Dis Clin North Am; 2013 Dec; 27(4):765-78. PubMed ID: 24275269
[TBL] [Abstract][Full Text] [Related]
8. Immune responses against virus and tumor in cervical carcinogenesis: treatment strategies for avoiding the HPV-induced immune escape.
Conesa-Zamora P
Gynecol Oncol; 2013 Nov; 131(2):480-8. PubMed ID: 23994536
[TBL] [Abstract][Full Text] [Related]
9. HPV & HPV vaccination: issues in developing countries.
Bharadwaj M; Hussain S; Nasare V; Das BC
Indian J Med Res; 2009 Sep; 130(3):327-33. PubMed ID: 19901442
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus vaccines: current issues & future.
Kawana K; Yasugi T; Taketani Y
Indian J Med Res; 2009 Sep; 130(3):341-7. PubMed ID: 19901444
[TBL] [Abstract][Full Text] [Related]
11. HPV and cervical cancer: updates on an established relationship.
Subramanya D; Grivas PD
Postgrad Med; 2008 Nov; 120(4):7-13. PubMed ID: 19020360
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of high-risk human papillomavirus type 16 and 18 in oral and cervical cancers in population from Gujarat, West India.
Patel KR; Vajaria BN; Begum R; Desai A; Patel JB; Shah FD; Shukla SN; Patel PS
J Oral Pathol Med; 2014 Apr; 43(4):293-7. PubMed ID: 24372728
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus vaccines for cervical cancer.
Murakami M; Gurski KJ; Steller MA
J Immunother; 1999 May; 22(3):212-8. PubMed ID: 10335480
[TBL] [Abstract][Full Text] [Related]
14. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research.
Lee SJ; Yang A; Wu TC; Hung CF
J Gynecol Oncol; 2016 Sep; 27(5):e51. PubMed ID: 27329199
[TBL] [Abstract][Full Text] [Related]
16. Anogenital neoplasia in AIDS.
Einstein MH; Kadish AS
Curr Opin Oncol; 2004 Sep; 16(5):455-62. PubMed ID: 15314515
[TBL] [Abstract][Full Text] [Related]
17. APOBEC-mediated genomic alterations link immunity and viral infection during human papillomavirus-driven cervical carcinogenesis.
Chen L; Qiu X; Zhang N; Wang Y; Wang M; Li D; Wang L; Du Y
Biosci Trends; 2017 Sep; 11(4):383-388. PubMed ID: 28717061
[TBL] [Abstract][Full Text] [Related]
18. Genotypic diversity of anogenital human papillomavirus in women attending cervical cancer screening in Harare, Zimbabwe.
Dube Mandishora RS; Christiansen IK; Chin'ombe N; Duri K; Ngara B; Rounge TB; Meisal R; Ambur OH; Palefsky JM; Stray-Pedersen B; Chirenje ZM
J Med Virol; 2017 Sep; 89(9):1671-1677. PubMed ID: 28390142
[TBL] [Abstract][Full Text] [Related]
19. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus in cervical screening and vaccination.
Crosbie EJ; Kitchener HC
Clin Sci (Lond); 2006 May; 110(5):543-52. PubMed ID: 16597323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
